TISI
ACHAT TOTAL: 8 500 titres (~194 820,00 $ US)
- Insiders
- Horton Anthony R, Lederman Evan S., McGinnis Pamela J.
- Total bought
- $194,820
- Total sold
- —
- Last activity
- 2026-08-24
- Last synced
-
2026-08-30 10:16:45
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-27
TISI presents a deeply concerning financial profile with chronic unprofitability, an interest coverage ratio below 1.0, and extreme leverage, making it structurally fragile regardless of any short-term catalyst.
The first sentence of the analysis written for TISI on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.8% | 26.2% | 24.5% | 24.0% | 21.6% | |
| Ebit Margin | -0.2% | 1.2% | -1.5% | -4.6% | -9.5% | |
| Ebitda Margin | 3.6% | 5.5% | 2.9% | -0.3% | -4.6% | |
| Operating Profit Margin | 1.6% | 1.2% | -1.5% | -4.7% | -16.0% | |
| Pretax Profit Margin | -5.2% | -4.1% | -8.2% | -17.5% | -22.2% | |
| Continuous Operations Profit Margin | -5.5% | -4.5% | -8.8% | -17.9% | -23.3% | |
| Net Profit Margin | -5.5% | -4.5% | -8.8% | 8.3% | -23.4% | |
| Bottom Line Profit Margin | -5.9% | -4.5% | -8.8% | -17.9% | -23.3% | |
| Current Ratio | 2.219 | 1.782 | 1.841 | 0.774 | 2.137 | |
| Quick Ratio | 1.874 | 1.560 | 1.619 | 0.693 | 1.949 | |
| Solvency Ratio | -0.033 | -0.004 | -0.073 | 0.214 | -0.225 | |
| Cash Ratio | 0.151 | 0.208 | 0.203 | 0.129 | 0.293 | |
| Price To Earnings Ratio | -1.208 | -1.468 | -0.381 | -0.146 | -0.202 | |
| Price To Earnings Growth Ratio | -0.034 | 0.029 | 0.007 | 0.004 | 0.007 | |
| Forward Price To Earnings Growth Ratio | -0.034 | 0.029 | 0.007 | 0.004 | 0.007 | |
| Price To Earnings Diluted Ratio | -1.208 | -1.468 | -0.381 | -0.146 | -0.202 | |
| Price To Earnings Diluted Growth Ratio | -0.034 | 0.029 | 0.007 | 0.004 | 0.007 | |
| Price To Book Ratio | 2.315 | 32.313 | 0.633 | 0.187 | 0.723 | |
| Price To Sales Ratio | 0.071 | 0.066 | 0.033 | 0.026 | 0.047 | |
| Price To Free Cash Flow Ratio | -3.082 | 4.222 | -1.347 | -0.282 | -0.707 | |
| Price To Operating Cash Flow Ratio | -5.604 | 2.467 | -2.626 | -0.413 | -1.058 | |
| Debt To Assets Ratio | 0.720 | 0.697 | 0.629 | 0.549 | 0.664 | |
| Debt To Equity Ratio | 12.726 | 212.044 | 7.799 | 2.875 | 9.040 | |
| Debt To Capital Ratio | 0.927 | 0.995 | 0.886 | 0.742 | 0.900 | |
| Long Term Debt To Capital Ratio | 0.912 | 0.995 | 0.870 | 0.040 | 0.887 | |
| Financial Leverage Ratio | 17.672 | 304.007 | 12.408 | 5.236 | 13.622 | |
| Working Capital Turnover Ratio | 6.399 | 6.066 | 37.626 | 14.909 | 4.355 | |
| Operating Cash Flow Ratio | -0.095 | 0.133 | -0.063 | -0.119 | -0.188 | |
| Operating Cash Flow Sales Ratio | -0.013 | 0.027 | -0.013 | -0.063 | -0.045 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.819 | 0.584 | 1.949 | 1.464 | 1.497 | |
| Debt Service Coverage Ratio | 0.455 | 0.631 | 0.342 | -0.016 | -0.972 | |
| Interest Coverage Ratio | 0.315 | 0.212 | -0.241 | -0.468 | -2.754 | |
| Short Term Operating Cash Flow Coverage Ratio | -0.558 | 1.070 | -2.108 | -0.189 | -53.153 | |
| Operating Cash Flow Coverage Ratio | -0.032 | 0.062 | -0.031 | -0.157 | -0.076 | |
| Capital Expenditure Coverage Ratio | -1.222 | 2.405 | -1.053 | -2.155 | -2.014 | |
| Dividend Paid And Capex Coverage Ratio | -1.222 | 2.405 | -1.053 | -2.155 | -2.014 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 12.296 | 8.304 | 13.831 | -116.925 | -12.298 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.9% | ▼-0.3% | ▲1.4% |
| Ebit Margin | -0.2% | ▼-1.5% | ▲2.7% |
| Ebitda Margin | 3.6% | ▼-1.9% | ▲2.2% |
| Operating Profit Margin | 1.6% | ▲0.4% | ▲5.5% |
| Pretax Profit Margin | -5.2% | ▼-1.1% | ▲6.2% |
| Continuous Operations Profit Margin | -5.5% | ▼-1.0% | ▲6.5% |
| Net Profit Margin | -5.5% | ▼-1.0% | ▲1.3% |
| Bottom Line Profit Margin | -5.9% | ▼-1.4% | ▲6.2% |
| Current Ratio | 2.219 | ▲0.437 | ▲0.468 |
| Quick Ratio | 1.874 | ▲0.314 | ▲0.335 |
| Solvency Ratio | -0.033 | ▼-0.029 | ▼-0.009 |
| Cash Ratio | 0.151 | ▼-0.056 | ▼-0.046 |
| Price To Earnings Ratio | -1.208 | ▲0.260 | ▼-0.527 |
| Price To Earnings Growth Ratio | -0.034 | ▼-0.063 | ▼-0.037 |
| Forward Price To Earnings Growth Ratio | -0.034 | ▼-0.063 | ▼-0.037 |
| Price To Earnings Diluted Ratio | -1.208 | ▲0.260 | ▼-0.527 |
| Price To Earnings Diluted Growth Ratio | -0.034 | ▼-0.063 | ▼-0.037 |
| Price To Book Ratio | 2.315 | ▼-29.998 | ▼-4.919 |
| Price To Sales Ratio | 0.071 | ▲0.005 | ▲0.022 |
| Price To Free Cash Flow Ratio | -3.082 | ▼-7.304 | ▼-2.843 |
| Price To Operating Cash Flow Ratio | -5.604 | ▼-8.071 | ▼-4.158 |
| Debt To Assets Ratio | 0.720 | ▲0.023 | ▲0.068 |
| Debt To Equity Ratio | 12.726 | ▼-199.318 | ▼-36.171 |
| Debt To Capital Ratio | 0.927 | ▼-0.068 | ▲0.037 |
| Long Term Debt To Capital Ratio | 0.912 | ▼-0.082 | ▲0.172 |
| Financial Leverage Ratio | 17.672 | ▼-286.335 | ▼-52.917 |
| Working Capital Turnover Ratio | 6.399 | ▲0.333 | ▼-7.472 |
| Operating Cash Flow Ratio | -0.095 | ▼-0.228 | ▼-0.028 |
| Operating Cash Flow Sales Ratio | -0.013 | ▼-0.039 | ▲0.009 |
| Free Cash Flow Operating Cash Flow Ratio | 1.819 | ▲1.234 | ▲0.356 |
| Debt Service Coverage Ratio | 0.455 | ▼-0.176 | ▲0.367 |
| Interest Coverage Ratio | 0.315 | ▲0.103 | ▲0.902 |
| Short Term Operating Cash Flow Coverage Ratio | -0.558 | ▼-1.628 | ▲10.430 |
| Operating Cash Flow Coverage Ratio | -0.033 | ▼-0.094 | ▲0.014 |
| Capital Expenditure Coverage Ratio | -1.222 | ▼-3.627 | ▼-0.414 |
| Dividend Paid And Capex Coverage Ratio | -1.222 | ▼-3.627 | ▼-0.414 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 12.296 | ▲3.992 | ▲31.254 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $63.6M | $56.2M | $28.8M | $22.0M | $37.5M | |
| Enterprise value | $395.0M | $389.1M | $349.0M | $302.5M | $451.2M | |
| EV / Sales | 0.44x | 0.46x | 0.41x | 0.36x | 0.57x | |
| EV / Op. cash flow | -34.81x | 17.09x | -31.77x | -5.68x | -12.73x | |
| EV / Free cash flow | -19.14x | 29.25x | -16.30x | -3.88x | -8.50x | |
| EV / EBITDA | 12.30x | 8.30x | 13.83x | -116.92x | -12.30x | |
| Net debt / EBITDA | 10.32x | 7.11x | 12.69x | -108.43x | -11.28x | |
| Current ratio | 2.22x | 1.78x | 1.84x | 0.77x | 2.14x | |
| Income quality | 0.23x | -0.59x | 0.14x | 0.35x | 0.19x | |
| Graham number | — | — | — | $103 | — | |
| Graham net-net | -$62 | -$70 | -$69 | -$60 | -$123 | |
| Tax burden | 105.5% | 109.4% | 106.4% | -47.7% | 105.6% | |
| Interest burden | 2386.4% | -331.0% | 563.0% | 376.0% | 232.9% | |
| Working capital | $146.3M | $133.9M | $147.2M | -$101.3M | $214.0M | |
| Invested capital | $344.7M | $337.3M | $382.9M | $160.7M | $506.3M | |
| Return on assets | -10.1% | -7.2% | -13.4% | 11.4% | -26.3% | |
| Operating ROA | 2.8% | 1.9% | -2.2% | -6.0% | -17.7% | |
| Return on tangible assets | -11.0% | -8.0% | -15.2% | 12.9% | -30.1% | |
| Return on equity | -179.1% | -2201.7% | -166.1% | 59.5% | -358.6% | |
| Return on invested capital | 3.6% | 2.7% | -3.2% | -8.6% | -23.7% | |
| Return on capital employed | 3.9% | 2.8% | -3.4% | -23.7% | -24.5% | |
| Earnings yield | -77.4% | -68.1% | -262.5% | 318.8% | -496.2% | |
| Free cash flow yield | -32.4% | 23.7% | -74.2% | -354.4% | -141.5% | |
| Capex / Op. cash flow | -81.9% | 41.6% | -94.9% | -46.4% | -49.7% | |
| Capex / Depreciation | 27.3% | 26.1% | 27.5% | 65.7% | 42.4% | |
| Capex / Sales | 1.0% | 1.1% | 1.2% | 2.9% | 2.2% | |
| SG&A / Sales | 24.3% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.1% | 0.3% | 0.2% | 0.0% | 0.9% | |
| Intangibles / Total assets | 7.8% | 9.5% | 12.0% | 12.2% | 12.5% | |
| Days sales outstanding | 77d | 91d | 93d | 98d | 97d | |
| Days payables outstanding | 23d | 24d | 20d | 19d | 26d | |
| Operating cycle | 100d | 113d | 115d | 119d | 118d | |
| Cash conversion cycle | 77d | 89d | 95d | 101d | 92d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-28 Northpointe Bancshares, Inc. Strengthens Leadership Team with Appointment of Joseph (JB) Long as Chief Operating Officer and Chief Credit Officer GRAND RAPIDS, Mich.--(BUSINESS WIRE)-- #NPB--Joseph (JB) Long to join Northpointe Bancshares, as Chief Operating Officer and Chief Credit Officer.
- 2026-08-28 Lobe Sciences Expands Leadership Team with New CFO Appointment Dr. David Kideckel, PhD, MBA, joins as Chief Financial Officer, bringing nearly two decades of life sciences, capital markets and corporate advisory experience Current CFO, Mirza Rahimani, transitions to Vice President of Finance, providing continuity across financial reporting and operations Appointment strengthens Lobe''s leadership team as the Company advances L-130, its differentiated conjugated psilocin therapeutic being developed at sub-hallucinogenic doses for chronic cluster headache VANCOUVER, BC / ACCESS Newswire / August 28, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FSE:LOBE.F) ("Lobe" or the "Company"), a clinical-stage biopharmaceutical company advancing differentiated therapeutics for serious conditions with significant unmet medical needs, today announced the appointment of Dr. David Kideckel, Ph.D.
- 2026-08-27 TBL Team Boxing League Announces Multi-Year Streaming Agreement with Fubo Sports Network Through 2027 Fubo''s free ad-supported streaming TV channel to begin streaming TBL MegaBrawl 4 live this weekend in the U.S. and Canada through the remainder of the 2026 postseason NEW YORK, Aug. 27, 2026 /PRNewswire/ -- TBL Team Boxing League ("TBL") today announced a new media agreement with Fubo Sports Network, the FAST (free ad-supported streaming TV) channel from FuboTV Inc. (NYSE: FUBO), that will bring live TBL fights and extensive library programming to the network through 2027. The agreement begins with Fubo Sports Network streaming TBL MegaBrawl 4 live this Sunday, August 30, marking the start of an expanded relationship that will provide viewers in the U.S. and Canada with access to some of the league''s biggest events and a growing slate of TBL programming.
- 2026-08-27 Sharon AI Expands Executive Leadership Team to Support Next Phase of Growth and Delivery NEW YORK, Aug. 27, 2026 /PRNewswire/ -- SharonAI Holdings Inc. (NASDAQ: SHAZ) ("Sharon AI" or the "Company"), a leading Australian Neocloud and trusted AI infrastructure partner, today announced an expansion of its executive leadership team to support the Company''s next phase of disciplined growth and delivery. The expanded structure establishes dedicated executive accountability across Sharon AI''s company-wide operations and AI infrastructure delivery as the Company scales its multi-site, multi-country AI Factory platform.
- 2026-08-26 Google Moves AI-Responsibility Team Out of DeepMind Lab in Latest Shake-Up Researchers have raised concerns about the change''s effect on their independence and ability to detect threats from newest models.
- 2026-08-26 Sun Life-Wilton Re Team Up to Expand Reinsurance, Asset Management SLF and Wilton Re''s partnership expands reinsurance and asset management, with Windsor Life Re targeting $10 billion in assets.
- 2026-08-26 Rivian''s Management Team Deserve Credit for Excellent Decision Making Amid Difficult Circumstances The EV industry generated only a fraction of its sales forecast in 2020 and 2021.
- 2026-08-25 Dolphin Subsidiary The Digital Dept. Grows Talent Division with 130 New Creators, 45% Team Increase and Two New Markets Roster now exceeds 380 creators as new hubs in Dallas and Boston join Los Angeles, New York, Miami and Nashville LOS ANGELES, CA / ACCESS Newswire / August 25, 2026 / The Digital Dept. (TDD), a subsidiary of Dolphin (Nasdaq:DLPN), today announced substantial growth across its talent management division over the past year, including a 130-creator increase to its talent roster, a 45% expansion of its team, and the addition of two new markets.
- 2026-08-25 Charlotte''s Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp''s Future The partnership expands access to trusted hemp wellness products while calling for commonsense federal standards that protect consumers and preserve responsible access Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte''s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in hemp wellness, and Edibles.com , a premier retailer and online marketplace, announced a strategic partnership to expand consumer access to trusted hemp wellness products. The partnership also signals a growing alignment in the hemp industry as a potential hemp ban approaches in November.
- 2026-08-25 Northisle Announces Additions to Board and Advisory Team VANCOUVER, British Columbia--(BUSINESS WIRE)---- $NCX #bc--Northisle Copper and Gold Inc. (TSX-V: NCX, OTCQX: NTCPF) (“Northisle” or the “Company”) is pleased to announce several additions to its Board of Directors and advisory team, including: Gerardo Fernandez – Director Dr. Gillian Davidson – Strategic Advisor Maurice Tagami – Process Design and Metallurgical Advisor Alex Davidson, Chairman, commented “I am excited to welcome Gerardo Fernandez, Gillian Davidson, and Maurice Tagami to the Northisle team.